@Article{,
AUTHOR = {Wigdan Al-Sukhni, Ami Grunbaum, Neil Fleshner},
TITLE = {Remission of hormone-refractory prostate cancer attributed to Essiac},
JOURNAL = {Canadian Journal of Urology},
VOLUME = {12},
YEAR = {2005},
NUMBER = {5},
PAGES = {2841--2842},
URL = {http://www.techscience.com/CJU/v12n5/62515},
ISSN = {1488-5581},
ABSTRACT = {Essiac is a popular complementary and alternative
medicine (CAM) that is utilized by many cancer patients
in North America. Much anecdotal reporting exists about
its cancer-fighting qualities, but so far no clinical trials
have been preformed to validate those claims. We describe
here the case of a 64-year-old man whose hormone-refractory prostate cancer responded well to Essiac tea.},
DOI = {}
}